AllHome raises ₹200 Cr Series B at $210 Mn valuation to scale interiors house-of-brands

PharmEasy cofounders' home interiors marketplace AllHome closed ₹200 Cr ($21 Mn) Series B led by Bessemer at ₹2,000 Cr valuation. Capital fuels physical experience centres, manufacturing, and tech across surfaces, hardware, facades, and lighting. ARR at ₹400 Cr, 18-20% EBITDA margin, targeting ₹1,000 Cr revenue in a $50 Bn market.

— Source publishedFri, 26 Jun, 2026, 15:40 IST·First seen Fri, 26 Jun, 2026, 15:43 IST·Source Inc42

What happened

AllHome, a home interiors house-of-brands marketplace founded by PharmEasy cofounders, raised ₹200 Cr Series B led by Bessemer at $210 Mn valuation. Funds will

Key facts

  • ₹200 Cr
  • $21 Mn
  • ₹2,000 Cr valuation
  • ₹400 Cr ARR
  • 18-20% EBITDA margin
  • ₹1,000 Cr revenue target
  • $50 Bn market

Why this matters

Track AllHome as a consolidator across surfaces, hardware, facades, and lighting—fresh capital plus PharmEasy-founder pedigree makes it the likely roll-up vehicle in home interiors.

What to watch

  • First 5 experience centre openings and same-store revenue disclosures
  • Q4 FY25 ARR update — needs to clear ₹500 Cr to stay on ₹1,000 Cr trajectory
  • Bessemer follow-on or new strategic (paints major, real-estate developer) entering cap table
  • EBITDA margin compression below 15% in next investor update
  • M&A announcements in home interiors house-of-brands space
  • Map AllHome's experience-centre rollout footprint vs Livspace and Asian Paints Beautiful Homes catchments
  • Track manufacturing capex allocation — surfaces and hardware are the highest-margin verticals to watch
  • Benchmark ₹400 Cr ARR against Livspace and HomeLane disclosed run-rates to validate market-share trajectory
  • Identify acquisition targets in lighting and modular hardware where AllHome lacks owned brands

Also reported by